ASCO 2025 Highlights

CancerCast by Weill Cornell Medicine

Aug 4, 2025Health

Drs. Manish Shah and Sarah Rutherford explore the groundbreaking research presented at the 2025 ASCO Annual Meeting. They discuss key developments from this year’s meeting, including new immunotherapy and targeted therap...

Related Episodes

Continue listening to more episodes from CancerCast.

A Breakthrough in Pancreatic Cancer Treatment – KRAS Targeting and Daraxonrasib

Aug 28, 2026 - 00:32:13

Pancreatic cancer treatment has entered an exciting new chapter. On August 26, 2026, the U.S. Food and Dr...

ASCO 2026 Highlights

Jul 31, 2026 - 00:33:35

The American Society of Clinical Oncology, or ASCO, Annual Meeting is the world’s largest oncology confer...

Cancer Survivorship – Living With and Beyond Cancer

Jun 5, 2026 - 00:32:53

Thanks to advances in cancer care, more people are living longer after a cancer diagnosis than ever befor...

Understanding Clonal Hematopoiesis: Blood Mutations Linked to Cancer, Heart Disease, Inflammation & More

May 22, 2026

As we age, our blood cells naturally develop mutations. With new sequencing technology, we can now identi...

What are the Latest Advances in Lung Cancer Treatment?

Apr 27, 2026

Lung cancer care is changing rapidly and new advances in surgery and medicine are at the forefront. In th...

Understanding BiTE Immunotherapy: How Bispecific T-Cell Engagers Target Cancer

Mar 20, 2026

Bispecific T-cell engager, or BiTE, therapy is an immunotherapy approach that helps the body’s own immune...

The Power of PSMA-Targeted Therapy for Prostate Cancer

Feb 13, 2026

Prostate-specific membrane antigen, or PSMA, is a protein expressed on the surface of prostate cancer cel...

The Treatment Toolkit for Liver Cancer and Metastatic Disease, from Surgery to Shockwaves and Beyond

Jan 14, 2026

Discover how liver cancer treatment is evolving in this episode of CancerCast. Dr. Manish Shah and Dr. Ju...